Antibody pharmacokinetics (PK) and nonlinear clearance

Life has been rather busy lately, but I have been using my spare time to learn new things too. Having come from a background working mostly with small molecules, I have decided to take some time to learn about the PK of biologics too. I spent the past week learning about the PK of antibodies. Let me share with you some of my learnings with you!

Most antibodies tend to follow a 2 compartment PK, with a distribution and elimination phase. Unlike small molecules where total clearance can generally be lumped under a single term of CL, however, antibody PK can be described using 2 terms for clearance instead. This is because antibodies tend to have 2 distinct clearance pathways – a linear clearance pathway via either elimination or catabolism in cells, and a saturable clearance pathway with targeted antigen mediated clearance. As there are 2 clearance pathways instead of 1, this can make the elimination slope of the antibody with saturated clearance very different from that of a small molecule with saturated clearance.

Check out the RShiny app to try adjusting the parameters yourself!
https://janicegoh.shinyapps.io/AntibodyPK/

Hope you learnt something with me! Feel free to add in your suggestions on what other non-small molecule therapeutics are important to learn about too, and if I missed out any important points in this explanation.

Unknown's avatar

About janice goh

Dr. Janice Goh graduated from NUS Pharmacy and is a registered pharmacist with the Singapore Pharmacy Council. She recently completed her PhD in the lab of Professor Rada Savic at the University of California, San Francisco (UCSF) School of Pharmacy. She is currently a senior scientist at the Bioinformatics Institute, A*STAR. Her work focuses on using quantitative systems pharmacology using translational pharmacometrics tools by capitalising on preclinical data to predict clinical outcomes prior to actual trials.
This entry was posted in Uncategorized and tagged , , , , , , , . Bookmark the permalink.

Leave a comment